Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a ...

Dentsply Sirona announced that it initiated a process to evaluate strategic alternatives for its Wellspect Healthcare ...

CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate ...

Wells Fargo initiated coverage of Dentsply Sirona (XRAY) with an Equal Weight rating and $20 price target The firm does not sees a “clean setup” into 2025 for Dentsply. It is hard to make a ...

NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...

Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated $2 ...

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Equal-Weight recommendation. As of January 29, 2025, the average one-year price ...

Dentsply SIrona (NASDAQ:XRAY)  earlier ticked higher by 2% amid some speculation that it may be the target of an activist investor. The speculation comes as Dentsply (NASDAQ:XRAY) said Tuesday it ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...